VLAHOVA; Petinka

Patent Applications and Registrations

Patent applications and USPTO patent grants for VLAHOVA; Petinka.The latest application filed is for "amorphous and crystalline forms of ido inhibitors".

Company Profile

1.19.21

VLAHOVA; Petinka - West Lafayette IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Amorphous And Crystalline Forms Of Ido Inhibitors App 20220169615 - POWERS; Jay Patrick ; et al.	2022-06-02
Amorphous and crystalline forms of IDO inhibitors Grant 11,236,049 - Powers , et al. February 1, 2	2022-02-01
Amorphous And Crystalline Forms Of Ido Inhibitors App 20200115342 - POWERS; Jay Patrick ; et al.	2020-04-16
Forms of rifaximin and uses thereof Grant 9,546,183 - Gushurst , et al. January 17, 2	2017-01-17
Forms Of Rifaximin And Uses Thereof App 20160200738 - Gushurst; Karen S. ; et al.	2016-07-14
Forms of rifaximin and uses thereof Grant 9,273,066 - Gushurst , et al. March 1, 2	2016-03-01
Forms of rifaximin and uses thereof Grant 9,034,892 - Gushurst , et al. May 19, 2	2015-05-19
Forms of rifaximin and uses thereof Grant 8,815,888 - Wu , et al. August 26, 2	2014-08-26
Forms Of Rifaximin And Uses Thereof App 20140179916 - Gushurst; Karen S. ; et al.	2014-06-26
Forms of rifaximin and uses thereof Grant 8,754,098 - Gushurst , et al. June 17, 2	2014-06-17
Forms Of Rifaximin And Uses Thereof App 20140141081 - Gushurst; Karen S. ; et al.	2014-05-22
New Forms Of Rifaximin And Uses Therof App 20130317225 - Wu; Yiduo ; et al.	2013-11-28
Forms of rifaximin and uses thereof Grant 8,569,326 - Gushurst , et al. October 29, 2	2013-10-29
Crystalline and amorphous forms of nalbuphine hydrochloride Grant 8,536,191 - Hanko , et al. September 17, 2	2013-09-17
Forms of rifaximin and uses thereof Grant 8,513,275 - Wu , et al. August 20, 2	2013-08-20
Forms of rifaximin and uses thereof Grant 8,486,956 - Gushurst , et al. July 16, 2	2013-07-16
Forms Of Rifaximin And Uses Thereof App 20130066079 - Gushurst; Karen S. ; et al.	2013-03-14
Forms Of Rifaximin And Uses Thereof App 20120316334 - Gushurst; Karen S. ; et al.	2012-12-13
Forms Of Rifaximin And Uses Thereof App 20120108620 - Wu; Yiduo ; et al.	2012-05-03
Forms Of Rifaximin And Uses Thereof App 20120076857 - Gushurst; Karen S. ; et al.	2012-03-29
Crystalline And Amorphous Forms Of Nalbuphine Hydrochloride App 20120029008 - Hanko; Jason ; et al.	2012-02-02
Forms of rifaximin and uses thereof Grant 8,067,429 - Gushurst , et al. November 29, 2	2011-11-29
Solid Forms of 2-(2,4-Difluorophenyl)-6-(1-(2,6-Difluorophenyl)Ureido)Nicotinamide) App 20110086891 - Hurrey; Michael ; et al.	2011-04-14
Salts and Crystal Forms App 20110053997 - Beliaev; Alexander ; et al.	2011-03-03
Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate Grant 7,829,723 - Blythe , et al. November 9, 2	2010-11-09
Forms Of Rifaximin And Uses Thereof App 20100239664 - Gushurst; Karen S. ; et al.	2010-09-23
Forms Of Rifaximin And Uses Thereof App 20100174064 - Gushurst; Karen S. ; et al.	2010-07-08
POLYMORPHIC FORMS OF (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)uriedo)phenyl)ethylcarbamate App 20090170915 - Blythe; Todd ; et al.	2009-07-02
Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4- (oxazol-5-yl)phenyl) ureido)phenyl) ethylcarbamate Grant 7,504,515 - Blythe , et al. March 17, 2	2009-03-17
Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4- (oxazol-5-yl)phenyl) ureido)phenyl) ethylcarbamate App 20070099972 - Blythe; Todd ; et al.	2007-05-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.